Prediction & Prevention Track

Autism Redefined 2010
Lecture Schedule 
Lymphatic Therapy
Student Scholars for Autism Program
Win-Win Parenting for the Autism Spectrum Child
Lecture Schedule  
NAA Presents: The Restraint and Seclusion Prevention Symposium
Homeopathy & Homotoxicology and Their Role in Reversing Vaccine Injury
Dynamics of Healthful Diet
Autism, the Brain, Thinking, & Behavior
Autism and Sexuality: A Conversation with Parents
The American Rally for Personal Rights
Lecture Schedule
Environmental Issues & Chronic Diseases Symposium
First Responders Training
Special Education Law Day
The Art of Cooking Special Diets
Verbal Behavior Workshop
CARD Feeding Clinic
EBCALA Legal & Advocacy Training
Current State of Autism Research
Biomedical Treatments for Autism 101: An Introduction to Scientifically Based Medical Treatment Options
In Spanish: Autism 101 - Today's Biomedical Treatments
Environmental Symposium
TACA Mentor Mixer
Lecture Schedule
Prediction & Prevention Track
ARCH Medical Center Parent Q&A
PANDAS Coverage
Lecture Schedule
Jenny McCarthy Keynote Address
Seizures Track
PANDAS Coverage
Advocacy Track
Adult Services & Residential Think Tank
Dr. Savely Yurkovsky Practitioner Training

Lecture Schedule
Seizures Track
True Health Symposium: Raising a Healthy Child in a Toxic World
Workshop: Interpreting Your Yasko Test Results

AHA Heroes Training
Arts Festival
Book Signings
Elias Tembenis Mini-Walk
TACA Mentors
Generation Rescue Angels Training
Spa Night




Friday, May 28
8:00-9:00 am - David Humphrey, JD

David Humphrey, Esq.
is the cofounder of the Autism Treatment Network (ATN), president of The Autism Forum, president of the Autism Coalition for Treatment (ACT!) and a board member of the Autism Research Institute (ARI), and the Northwest Autism Foundation (NWAF).
9:00-10:00 am - Kenneth Bock, MD

Kenneth Bock, MD
received his MD with Honor from the University of Rochester School of Medicine. A pioneer and leader in the field of integrative medicine for over two decades, Dr. Bock's expertise lies in bringing a comprehensive integrative medicine approach to complex medical problems, including the 4-A disorders - autism, ADHD, asthma and allergies. His Healing Program for the 4-A disorders is detailed in his latest book, Healing the New Childhood Epidemics: Autism, ADHD, Asthma and Allergies, which has received international acclaim.
10:30-11:30 am - Martha Herbert, MD, PhD

Martha Herbert, MD, PhD
is a pediatric neurologist at the Massachusetts General Hospital in Boston and Harvard Medical School, and an affiliate of the Harvard-MIT-MGH Martinos Center for Biomedical Imaging. She is director of the TRANSCEND Research Program (Treatment Research and Neuroscience Evaluation of Neurodevelopmental Disorders,, which takes a whole body approach to brain research to guide the development of sensitive methods for measuring brain changes from treatment so that we can have objective measures for treatment outcome studies. She is also pursuing multisystem prospective at-risk infant sibling research starting prenatally and at birth for the infant to monitor medical and physiological development in parallel with behavioral development so that we can identify measures of risk for autism that will allow targeted medical intervention as early as possible.
11:30 am-12:30 pm - Doreen Granpeesheh, PhD, BCBA-D

Doreen Granpeesheh, PhD
is the founder and executive director of the Center for Autism and Related Disorders (CARD) and the founder and president of the board of Autism Care and Treatment Today (ACT Today). Dr. Granpeesheh received her PhD in psychology from UCLA and is licensed by the Medical Board of California and the Texas and Arizona State Boards of Psychologists. Dr. Granpeesheh holds a Certificate of Professional Qualification in Psychology from the Association of State and Provincial Psychology Boards, is a board certified behavior analyst and has been providing behavioral therapy for children with autism since 1979. She is a member of the Defeat Autism Now! Executive Council, on the Scientific Advisory Board of the US Autism and Asperger's Association and first vice chair of the national board of directors of the Autism Society of America. Dr. Granpeesheh is a member of the Autism Human Rights and Discrimination Initiative steering committee and on the oversight committee of the Department of Developmental Disabilities for the State of Arizona.
1:45-2:45 pm - Kendal Stewart, MD, and Lisa Hunter Ryden

Kendal Stewart, MD
is board certified in otolaryngology with fellowship training in neurotology/skull base surgery. His experience includes advanced training in neurosurgical, neurological and immunological disorders. He has extensive experience with advanced neurological and audio-vestibular techniques and has authored two medically-related patents in this area. Dr. Stewart has had specific research interests in vestibular disorders, athletic injuries of the nervous system and processing/sensory integration disorders. Dr. Stewart has developed innovative and highly effective treatment protocols for neurological diseases including Meniere's disease, imbalance, vertigo, autism spectrum disorders, and "post-concussion" syndrome. He has authored papers and is extensively involved in lectures and instructional courses for physicians, therapists and other health care professionals. He has also held an associate professorship at the University of Texas Medical School at San Antonio.

Lisa Hunter Ryden, MT (ASCP), MBA
is a parent of two children with neuroimmune disorders. Her oldest son suffered neurological regression at 12 months old and was later diagnosed with autism, and her youngest son has allergies and asthma. Together with Dr. Stewart, she hosts a monthly radio show on Autism One Radio called, "The Parent and Professional Partnership for Healing our Children," which presents a unique team approach to the recovery journey and chronicles her children's progress using evidence-based biomedical interventions and therapies. Both of her children have similar diagnostic test results, which has led her to research the epigenetic origins of these disorders. Lisa has a BS degree in Medical Technology, an MBA degree in International Management, and graduate coursework in molecular genetics and immunology. She has spent the past 20 years working in the medical diagnostic industry. She is a frequent public speaker and writer for autism and disability organizations, and has met with media and elected officials to educate them about the diagnosis and treatment of the neuroimmune disorders.


Prediction and Prevention of ASD: Signs to watch out for and treatments that will help you avoid the diagnosis of autism 8:00 am - 12:30 pm

Dave Humphrey, JD, Kenneth Bock, MD, Martha Herbert, MD, PhD, and Doreen Granpeesheh, PhD, BCBA-D, will take attendees through a 4-part series emphasizing the importance of early detection of the symptoms of ASD as helping practitioners alter the course of diagnosis. With early detection, practitioners can identify treatment strategies and interventions that, when provided intensively, can prevent children from developing the full symptom criteria of autism. These red flags and treatment options will be reviewed.

The speakers will include data from young siblings of children with autism illustrating that children who receive treatment at a very early age do, in fact, avoid receiving an ASD diagnosis as their symptoms are effectively reversed. Here's just a sample:

Autism in Infancy: Predetermined or Produced by Active Treatable Processes? presented by Martha Herbert, MD, PhD

Is autism stamped into the brain by genes from conception? Or does it develop? If it develops, what influences that development? And how can we influence those influences? If the brain isn't indelibly stamped with autism, then what happens to it to transform it so that it starts producing autistic behaviors? At what range of prenatal or postnatal ages might this start? Is there any way of detecting those changes in living babies? If we can head off the emergence of the debilitating features of autism, how can we prove we did this if we can't be sure ahead of time whether this might be where a baby is headed? Does it matter whether our measures are specific for autism or not? How can we make medical screening and prevention measures the standard of care? What would we need to demonstrate to make this happen, and how would we do this most powerfully? What are the biggest obstacles we would need to overcome? What would population-wide health-promotion and health-protection measures look like? What would be the most efficient and effective ways to carry this out? How much is our success in this a function of how well we answer the above questions?

Ken Bock, MD, presents: Considerations for Prevention of Autism Spectrum Disorders

The prevalence of autism spectrum disorders has increased at least 1500% in the last 20 years. More so, in the last 2 years, we have seen a further increase from 1:150 children to 1:91 children. There is no known cause and no known cure. However, emerging scientific research, coupled with clinical experience has provided us with various suspected causative factors, coupled with genetic predisposition. These have helped us to formulate treatment strategies that have resulted in improvement of the majority of the children treated, as well as an increasing number of children treated recovering and losing their diagnosis.

Chemical and heavy metal toxicities appear to be significant contributing factors to the rising rates of autism in this country and around the world. These chemical exposures persist. Extensive toxicants have been noted in the umbilical cord blood of pregnant women, which should be the source of nourishment for the developing fetus. Yet neonates, infants and children continue to be exposed to these persistent environmental toxicants. Prevention becomes paramount in an overall approach to lessening the impact of this epidemic of autism spectrum disorders, and this lecture will explore possible avenues for this.

Kendal Stewart, MD & Lisa Hunter Ryden, MT (ASCP), MBA 1:45 - 2:45 pm

Preventative and Management Strategies for the Neuroimmune Disorders

Dr. Kendal Stewart and Lisa Hunter Ryden will present key areas related to prediction, prevention, diagnosis, and management of neuroimmune disorders, particularly disorders associated with behavioral regression and neuroimmune symptoms such as allergies, asthma, ADD and autism. For preventative and predictive strategy, they will discuss the prenatal health status of the mother and how this impacts the newborn's neuroimmune system, the use of newborn screening biomarkers to assess immune function, and the birth parents' genetic and medical histories. For diagnosis of the neuroimmune disorders, Dr. Stewart will discuss Sensory ViewR, the diagnostic system he patented which provides an integrated and easy-to-read graphical illustration of the patient's neurosensory and vestibular system function, and Lisa will discuss the prioritization and cost management of laboratory biomarker testing using genetic and protein biomarkers. As hosts of the monthly show on Autism One Radio titled, "The Parent and Physician Partnership for Healing our Children," Dr. Stewart and Lisa discuss their team approach to management of the neuroimmune disorders and the ongoing recovery of Lisa's son from many medical symptoms related to his disorder of autism. In 2007, Lisa's son presented clinically as nonverbal with a diagnosis of heavy metal toxicity, gastrointestinal dysfunction, multiple allergies, and pathogenic burden. Today, he has recovered from many of those medical symptoms and is now speaking in sentences.